Safety Alert | Invokana Linked to Amputation Risks

The FDA issued a black-box warning on May 16, 2017 for the popular type-2 diabetes drug Invokana following studies confirming that patients who took the drug were twice as likely to need their toes, feet or legs amputated.   If you or a loved one had an amputation while taking Invokana, we can help you with your potential legal claim to recover medical bills, wage loss, and other losses.  Fill out our Invokana free case review form or call us at 1.800.887.8029 to learn more.

FREE CASE REVIEW

 

During clinical studies, researchers found that patients given Invokana (canagliflozin) had double the risk of amputation compared to those taking a placebo.  A block-box warning is the most serious safety alert given by the FDA.  It requires the manufacturer, Johnson & Johnson, to add information about amputation risks at the top of the labeling surrounded by a thick, black border.

In addition to these latest warnings, the drug has been linked to kidney failure and ketoacidosis – a serious condition where the body produces high levels of blood acids called ketones.  This medication is in a class of drugs called sodium-glucose cotransporter 2 inhibitors (SGLT2) used in patients with type-2 diabetes to lower their blood sugar levels.

How We Can Help

If you or a loved one have had an amputation and were taking Invokana you may want to consider your potential legal claim. Our team is ready to evaluate your potential claims and help you navigate your next steps. For more information, or to speak with someone about your potential case, please call us at 1.800.887.8029. Zimmerman Reed is experienced in helping individuals injured by prescription drugs and we welcome your questions.